Nearly 9K elementary students in Waterloo region with out-of-date vaccination records face suspension
In a release sent out Friday, Region of Waterloo Public Health tell families they have five weeks to update vaccination records, get vaccinated or apply for an exemption.
If these steps aren't taken, the 8,981 children who have been contacted by public health will be suspended from school starting April 2.
"Vaccination protects everyone and keeps schools healthy by stopping the spread of serious and preventable disease," Dr. Hsiu-Li Wang, Waterloo region's medical officer of health said in the release.
"Children who are not vaccinated are at increased risk of getting infections and spreading diseases to others. The enforcement of the Immunization of School Pupils Act is critical for ensuring the health and wellbeing of our community."
The suspension orders are based on the vaccine records reported on or before Feb. 4. Families can update immunization records on the Region of Waterloo's website under "vaccine reporting."
Largest outbreak of measles in 30 years
The orders comes at a time when 78 new measles cases were identified in Ontario over the course of two weeks.
On Thursday, public health officials called it the largest outbreak the province has seen in almost 30 years.
The new cases bring Ontario's total this year to just over 140, far surpassing the 101 total infections recorded in the province between 2013 and 2023.
The epicentre of Ontario's outbreak has been in the Southwestern and Grand Erie public health regions.
Health officials said the concentration of cases in unvaccinated people could explain how quickly the outbreak spread over the last two weeks.
As a result of the outbreak, 18 kids have been hospitalized in Ontario, including one who required intensive care.
Dr. Sarah Khan, an associate professor in the pediatrics department at McMaster University, said on Thursday that people are at risk because vaccination rates have gone down and it's important that people keep their immunization records up to date.
"It's probably good we all just know our status because if you get that call from public health, they're going to ask you: 'Are you sure you're immune?' And you're going have to provide that proof," Khan said.
"And so, I think it's just better we all kind of check that and get caught up."
Khan said prevention is key to stopping the spread of measles and prevention means vaccination. She said if there is a community that is "entirely non-immune," it will spread rapidly within that community.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
3 days ago
- CBC
Worldwide shortages of hormone replacement therapy medication leave women struggling
The long list of symptoms of perimenopause and menopause range from inconvenient to debilitating. Hormone replacement therapy (HRT) can be a huge help, but a worldwide shortage of HRT is leaving women in the lurch. Alison Shea, an Assistant Professor in Obstetrics and Gynecology and Psychiatry at McMaster University explains why the shortage is so problematic. Karen Golden can vividly recall the symptoms of menopause she experienced during a shortage of her hormone replacement therapy (HRT) medication five years ago. "It wasn't a good time," recalled the Toronto-based lawyer. She had started undergoing HRT to deal with sleep issues and anxiety related to menopause several years ago. But in 2020, there was a shortage of the medication she was taking. Her doctor tried to switch her to other products, but they caused side-effects, so Golden made the decision to go off HRT altogether and the symptoms returned. Golden is one of many women around the world who have been affected by worldwide shortages of HRT medications, used to help manage menopausal symptoms. The shortages have left women in the lurch, unable to find relief from symptoms that range from inconvenient to debilitating. Drug Shortages Canada, an online database of drug shortages and discontinuations in the country, shows that since 2017, there have been 92 shortages and four discontinuations of products containing estradiol, a form of estrogen commonly used in HRT drugs. The products include transdermal patches, pills, vaginal rings, topical gels and creams. "If the woman can't get her medication, she's not going to be functioning as well. She's not going to be sleeping. Her mood may drop significantly," Dr. Alison Shea, an obstetrician-gynecologist and assistant professor at McMaster University, told CBC Radio's Day 6. Menopause occurs 12 months after a woman's last menstrual period. Perimenopause, the stage leading up to that, comes with hormonal changes that last an average of seven years, but can be longer for some. During this time, many women experience hot flashes, night sweats, trouble sleeping, changes in mood and libido, or difficulty concentrating — symptoms that can be treated by hormonal therapy. HRT shortages also put a burden on doctors and pharmacists, Shea said, since they have to spend extra time looking for alternatives for their patients — adding stress to an already overloaded health-care system. "So really, it's chaos for everyone," she said. According to a written statement from Health Canada, at the moment, HRT drugs are generally available in Canada with the exception of estrogen/progestin patches. The estimated end date of this shortage is July or August. 'Dangerous and unethical' Meanwhile, some women who rely on these medications feel the shortages aren't being adequately addressed and worry their health is not being taken seriously. Though Golden stopped taking HRT due to the 2020 shortage, she was able to go back on her original medication last year. But after just a few months, she learned it was again on back order. As she was running out of her medication, she reached out directly to the pharmaceutical company behind the drug. They told her that they were fulfilling orders in "an equitable way" and that it would take some weeks to stabilize. Golden didn't accept that response. After some back and forth with the company, they agreed to ship some stock to her local pharmacy. But she doesn't think other women should have to go to such extremes to have reliable access to HRT drugs. "It would be helpful if the decision-makers in this knew that giving people medication for their physical and mental health and then yanking it away is dangerous and unethical," she said. A complex supply chain Mina Tadrous, a pharmacist and associate professor in the facility of pharmacy at the University of Toronto, said it can be complicated to pinpoint the exact source of a shortage. Drugs often pass through multiple countries and several different facilities before reaching Canadian pharmacies, he said. "If anything along that supply chain breaks, it sort of feels like a slow-moving train because it takes a few weeks or months for it to hit," Tadrous said. Also, manufacturing hormones is particularly specialized, involving specific chemical reactions and careful handling of sensitive molecules. "You have a product that's a little harder to make, and then all of a sudden, you also have very few companies that are active in the marketplace," he said. Producing a drug can take anywhere from 18 to 24 months — from sourcing raw materials to production to quality control to distribution, said Christian Ouellet, vice-president of corporate affairs at pharmaceutical company Sandoz Canada, which produces a range of HRT products. "Manufacturing a molecule is not like manufacturing bread — it's complex," he said, noting that manufacturers always want to meet quality, efficacy and safety requirements. Though there have been shortages of HRT drugs from Sandoz Canada over the last few years, Ouellet said the company is currently meeting demand. In a written statement, Health Canada spokesperson Mark Johnson said when drug shortages happen, it "works closely with manufacturers, health-care providers, and provinces and territories to monitor the situation and explore shortage mitigation options." With HRT drugs specifically, shortages are driven primarily by a recent surge in demand, which Ouellet said is "several times more than what it was five years ago." According to aggregate claims data from Manulife, one of the top insurance providers in Canada, there was a 21 per cent increase in the number of women aged 45 to 65 seeking HRT for menopausal symptoms from 2020 to 2023. Expanding HRT use Several experts point to social media and greater advocacy among women for their own health as factors driving demand. A 2002 study linking HRT drugs to increased instances of breast cancer and heart disease has also been debunked in the last decade, resulting in more doctors prescribing them. Many of these medications are also prescribed in gender-affirming hormone therapy. According to Dr. Kate Greenaway, medical director of Foria, a virtual clinic providing gender-affirming care, these shortages "can be a little more profound" for the trans and non-binary community, because of the limited number of alternatives in Canada. There have also been shortages of other hormones used in gender-affirming care, she said, such as androgen blockers and testosterone, and it's difficult to predict which products will become scarce and how long the shortage will last. Tadrous said he's skeptical that we'll see the end of HRT shortages without major action, like bolstering production or giving pharmacists the authority to replace a therapy that's not available with another equivalent drug or combination of drugs. Despite the fact that demand for HRT has grown, it's still a relatively small market compared to other drugs, Tadrous said, noting that increasing the market size for HRT drugs — in other words, prescribing it to more women — might actually incentivize manufacturers to ramp up production overall. "If we actually used it more often, then the pharmaceutical companies would want to make more," he said. WATCH | Empowering women to talk about menopause: The push to rebrand menopause gains momentum 3 years ago The menopause movement is heating up, empowering women to talk more openly about their symptoms and demand treatment. CBC's Ioanna Roumeliotis steps into the world of menopause advocacy and uncovers a passionate community fighting a system that unfairly sidelines women's health. Some menopause specialists do want to see access to HRT drugs expanded. Dr. Michelle Jacobson, a gynecologist who sits on the board of the Canadian Menopause Society, thinks every woman who is of average age for menopause, doesn't have other major health issues, and is experiencing symptoms like hot flashes and night sweats should be offered hormone therapy. "That is agreed upon by every guideline and every organization out there who have opinions on menopause," she said. But she adds that some physicians are still hesitant to prescribe hormone therapy — sometimes just from a lack of knowledge.
CBC
4 days ago
- CBC
Pier 4 Park Beach closed after blue-green algae confirmed in the water, city says
The City of Hamilton has closed the Pier 4 Park Beach due to confirmed blue-green algae. The city said in a news release on Friday, finding the toxin-producing algae at Pier 4 "serves as a strong indicator that blue-green algae can be present within the broader watershed." People and pets should avoid all contact with the water at the Pier 4 Park Beach shoreline, the city said. The city also recommends washing with clean water immediately if someone comes in contact with the beach water at Pier 4. "People who come into contact with the visible blue-green algae or ingest water containing blue-green algae may experience skin irritation, rash, sore throat, sore red eyes, swollen lips, fever, nausea and vomiting and/or diarrhea," said the city in the news release. If anyone has come in contact with the water recently and is experiencing symptoms like headaches, fever, diarrhea, abdominal pain, nausea or vomiting, should contact their primary care provider. A McMaster University water scientist told CBC Hamilton last year "a small dog could be killed" if it drank water with blue-green algae. "Do not let a dog off-leash near a water body that has blue-green algal blooms because the microcystin toxin is deadly," said Gail Krantzberg, a water scientist and professor in the university's masters of engineering and public policy program. The city also said signs will be posted at the park advising the closure, which will be in effect until the blue-green algae subsides. The algae grows in slow-moving or still shallow, warm water and can produce an "offensive" smell as it decays, the city said. In December, city staff presented preliminary research into ways to help mitigate blue-green algae blooms after it caused putrid smells for several weeks last summer. The report recommends testing out several "experimental treatments" — like circulating the water, introducing aquatic plants that absorb nutrients and limit sun exposure, and skimming the blooms off the surface — to help prevent or remove the rotting mats of algae but cautioned residents this is not the type of problem with a quick fix.
CTV News
5 days ago
- CTV News
Canadian COVID-19 study misrepresented in false claims about mass ‘spraying' of vaccine
A jar of empty COVID-19 vaccine vials is shown at a pharmacy in Toronto on Wednesday, April 6, 2022. THE CANADIAN PRESS/Nathan Denette The second phase of human trials for inhaled aerosol COVID-19 vaccine 'AeroVax' is ongoing at a Canadian university. Online posts claimed the vaccine could or would be used in mass airborne vaccinations without consent, or that the university received funding from the Bill & Melinda Gates Foundation. These claims are false. The vaccine, which is still in its trial phase and not approved for use in Canada, would involve an inhaler — not mass spraying. The Canadian Press could find no evidence of Bill Gates's involvement in the study, which is funded by the Canadian Institutes of Health Research. The claim 'Canada Advances Plan to 'Vaccinate' Public with Bill Gates-Funded Covid mRNA Aerosols,' reads part of an Aug. 3 X post. The post mentions Canada's plan to 'vaccinate the general public using aerosols' through the 'AeroVax' vaccine, which is currently undergoing its second phase of human trials at McMaster University in Hamilton, Ont. The post uses an airplane emoji and includes an image of a crop duster aircraft and Bill Gates, and links to an article that claims Gates's non-profit foundation is funding the testing because it funds the wider university. Similar posts from earlier this year claimed the vaccine would be inhaled through the air or that Bill Gates was an investor. Rating: False The researchers conducting the AeroVax study told The Canadian Press the vaccine is not designed for mass vaccination. 'Confirming that the AeroVax Inhaled COVID vaccine is designed to be administered to individuals and it not designed to be 'sprayed' on the public via aircraft as a form of mass vaccination for people who don't consent,' research co-ordinator Marilyn Swinton said in an email. The study protocol, as well, outlines the vaccine would be inhaled by individuals through a mouthpiece using a nebulizer. An article from McMaster about the study's Phase 1 results noted the vaccine is 'delivered directly to the lungs as an inhaled mist' instead of by needle. The study's researchers believe the vaccine could prevent breakthrough COVID-19 infections. Findings from preclinical studies and the Phase 1 trial show the vaccine could be 'more effective at inducing immune responses than traditional injected vaccines are, because it directly targets the lungs and upper airways,' according to McMaster. Keyword searches show spraying the vaccine through aircraft or without the public's consent isn't mentioned or implied by the study at all. A keyword search on the McMaster website shows the Bill & Melinda Gates Foundation provides certain funding opportunities researchers can apply for. But the non-profit is not involved in the AeroVax study. Swinton, the study's research co-ordinator, said the AeroVax study is funded by Canadian Institutes of Health Research, the federal agency responsible for medical research funding in Canada. In March, the agency provided $8,266,315 for the vaccine's second phase trial over three years. Sources Claim posted to X Aug. 3, 2025 (archived) and similar claims posted to X May 2, 2025 here (archived) and here (archived post, archived video) Frank Bergman. Canada Advances Plan to 'Vaccinate' Public with Bill Gates-Funded Covid mRNA Aerosols. Slay News website. Aug. 3, 2025 (archived) Adam S Komorowski et al. AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans. ERJ Open Research via National Library of Medicine website. June 9, 2025 (archived) Blake Dillon. Promising results from Phase 1 human trials of McMaster's inhaled COVID-19 vaccine. McMaster University website. July 4, 2025 (archived) Blake Dillon. Made-at-McMaster inhaled COVID-19 vaccine begins phase-2 human trial. McMaster University website. March 10, 2025 (archived) A phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans. Canadian Institutes of Health Research website. Accessed Aug. 5, 2025 (archived) Marissa Birnie, The Canadian Press
